Skip to main content
logo
Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
18.93
+0.93 (5.17%)
At close: Oct 15, 2026, 4:00 PM EDT
18.92
-0.01 (-0.05%)
After-hours: Oct 15, 2026, 7:30 PM EDT

Nuvectis Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
617193105145110-
Market Cap Growth
301.79%85.02%-27.66%31.58%--
Enterprise Value
5951588712286-
Last Close Price
18.937.555.418.347.50-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
55.6410.5010.7611.847.72-
P/TBV Ratio
67.9110.5010.7611.847.72-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-2.44-1.72-1.91-1.57-1.41-1.35
Quick Ratio
1.672.382.082.743.232.37
Current Ratio
1.682.382.092.753.302.41
Return on Equity (ROE)
-214.58%-188.03%-173.41%-168.51%-206.81%-609.74%
Return on Assets (ROA)
-73.07%-68.50%-65.64%-69.14%-83.30%-
Return on Capital Employed (ROCE)
-317.90%-149.80%-204.30%-179.50%-126.80%-136.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.91%-13.67%-18.18%-15.40%-17.38%-
Buyback Yield / Dilution
-21.66%-27.46%-10.01%-22.90%-196.55%-9.44%
SEC Filings: 10-K · 10-Q